Results 281 to 290 of about 514,858 (318)

FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours. [PDF]

Pituitary
Orsmond A, Krishnan G, Palmer LJ, De Sousa SMC, McCormack A.   +4 more
europepmc   +1 more source

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report. [PDF]

Front Endocrinol (Lausanne)
Kubo H, Wada R, Sekikawa N, Nomura Y, Yamada M, Inoue M, Hattori N, Yamazaki Y, Sugimoto K.   +8 more
europepmc   +1 more source

Adult Growth Hormone Deficiency (AGHD) and Outcomes (NordiNet and ANSWER). [PDF]

J Endocr Soc
Carmichael JD, Kargi AY, Dichtel L, Kelepouris N, Nedjatian N, Fridman M, Weber MM.   +6 more
europepmc   +1 more source

Paediatric Endocrinology: Before and Beyond ‘Ringing the Bell’

Journal of Paediatrics and Child Health, EarlyView.
Louise S. Conwell
wiley   +1 more source

Refining Endoscopic and Combined Surgical Strategies for Giant Pituitary Adenomas: A Tertiary-Center Evaluation of 49 Cases over the Past Year. [PDF]

Cancers (Basel)
Emengen A, Yilmaz E, Gokbel A, Uzuner A, Balci S, Tavukcu Ozkan S, Ergen A, Caklili M, Cabuk B, Anik I, Ceylan S.   +10 more
europepmc   +1 more source

Intriguing Encounter: Unveiling Squamous Cell Carcinoma Lung with Rare Bilateral Renal and Pituitary Metastasis on [18F]-FDG PET/CT. [PDF]

Indian J Nucl Med
Singh P, Khandelwal Y, Mishra V, Jain B.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diagnosis and Management of Pituitary Adenomas: A Review.

Journal of the American Medical Association (JAMA), 2023
Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell lineage and include functioning tumors, characterized by the secretion of pituitary hormones, and nonfunctioning tumors.
N. Tritos, K. Miller
semanticscholar   +1 more source

Biomarkers of Pituitary Neoplasms: A Review (Part II)

Neurosurgery, 2010
Several new markers have shown a capacity to predict the clinicopathological behavior of pituitary neoplasms; these markers have shown potential to correlate with tumor subtype and size and patient age and sex.
F. Salehi, A. Agur, B. Scheithauer, K. Kovacs, R. Lloyd, M. Cusimano   +5 more
semanticscholar   +1 more source

Ki-67 in pituitary neoplasms: a review--part I.

Neurosurgery, 2009
KI-67, A MARKER of cellular proliferation, has been studied extensively in pituitary neoplasia. It is of relevance to various clinicopathological parameters, including tumor subtype, size, invasiveness, and recurrence, as well as patient age and sex ...
F. Salehi, A. Agur, B. Scheithauer, K. Kovacs, R. Lloyd, M. Cusimano   +5 more
semanticscholar   +1 more source